HomepageDNA • NYSE
add
Ginkgo Bioworks Holdings Inc
$Â 7,84
Na sluitingstijd:(1,15%)+0,090
$Â 7,93
Gesloten: 25 apr, 18:37:44 GMT-4 · USD · NYSE · Disclaimer
Vorige slotkoers
$Â 7,87
Dag-range
$Â 7,61 - $Â 7,95
Jaar-range
$Â 5,00 - $Â 45,20
Beurswaarde
431,46Â mln. USD
Gem. volume
1,42Â mln.
Koers/winst
-
Dividendrendement
-
Primaire beurs
NYSE
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (USD) | dec 2024info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 43,85Â mln. | 26,16% |
Bedrijfskosten | 128,36Â mln. | -29,52% |
Netto inkomsten | -107,53Â mln. | 49,20% |
Netto winstmarge | -245,25 | 59,74% |
Winst per aandeel | -1,21 | 58,78% |
EBITDA | -78,48Â mln. | 44,39% |
Effectief belastingtarief | 0,30% | — |
Balans
Totale activa
Totale passiva
| (USD) | dec 2024info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 561,57Â mln. | -40,52% |
Totale activa | 1,38Â mld. | -17,29% |
Totale passiva | 661,39Â mln. | 16,40% |
Totaal aandelenvermogen | 716,06 mln. | — |
Uitstaande aandelen | 54,37 mln. | — |
Koers-boekwaardeverhouding | 0,60 | — |
Rendement op activa | -16,47% | — |
Rendement op kapitaal | -19,39% | — |
Kasstroom
Nettomutatie in liquide middelen
| (USD) | dec 2024info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | -107,53Â mln. | 49,20% |
Operationele kasstroom | -42,44Â mln. | 26,62% |
Kasstroom uit beleggingen | -13,08Â mln. | 71,97% |
Kasstroom uit financiering | -203,00K | 67,88% |
Nettomutatie in liquide middelen | -55,80Â mln. | 46,88% |
Vrije kasstroom | -64,47Â mln. | -146,17% |
Over
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021. Wikipedia
CEO
Opgericht
2008
Hoofdvestiging
Website
Werknemers
834
